CILP and myocardial infarction: Compared with wild-type mice, Cilp1 knock out mice had better cardiac function, reduced number of immune cells and myofibroblasts, attenuated collagen expression, and enhanced microvascular survival after MI injury, which indicated Cilp1 could be a therapeutic target for cardiac fibrosis [108].